How women are treated during facility-based childbirth in four countries: a cross-sectional study with labour observations and community-based surveys.


Journal

Lancet (London, England)
ISSN: 1474-547X
Titre abrégé: Lancet
Pays: England
ID NLM: 2985213R

Informations de publication

Date de publication:
09 11 2019
Historique:
received: 26 04 2019
revised: 08 08 2019
accepted: 15 08 2019
pubmed: 13 10 2019
medline: 18 12 2019
entrez: 13 10 2019
Statut: ppublish

Résumé

Women across the world are mistreated during childbirth. We aimed to develop and implement evidence-informed, validated tools to measure mistreatment during childbirth, and report results from a cross-sectional study in four low-income and middle-income countries. We prospectively recruited women aged at least 15 years in twelve health facilities (three per country) in Ghana, Guinea, Myanmar, and Nigeria between Sept 19, 2016, and Jan 18, 2018. Continuous observations of labour and childbirth were done from admission up to 2 h post partum. Surveys were administered by interviewers in the community to women up to 8 weeks post partum. Labour observations were not done in Myanmar. Data were collected on sociodemographics, obstetric history, and experiences of mistreatment. 2016 labour observations and 2672 surveys were done. 838 (41·6%) of 2016 observed women and 945 (35·4%) of 2672 surveyed women experienced physical or verbal abuse, or stigma or discrimination. Physical and verbal abuse peaked 30 min before birth until 15 min after birth (observation). Many women did not consent for episiotomy (observation: 190 [75·1%] of 253; survey: 295 [56·1%] of 526) or caesarean section (observation: 35 [13·4%] of 261; survey: 52 [10·8%] of 483), despite receiving these procedures. 133 (5·0%) of 2672 women or their babies were detained in the facility because they were unable to pay the bill (survey). Younger age (15-19 years) and lack of education were the primary determinants of mistreatment (survey). For example, younger women with no education (odds ratio [OR] 3·6, 95% CI 1·6-8·0) and younger women with some education (OR 1·6, 1·1-2·3) were more likely to experience verbal abuse, compared with older women (≥30 years), adjusting for marital status and parity. More than a third of women experienced mistreatment and were particularly vulnerable around the time of birth. Women who were younger and less educated were most at risk, suggesting inequalities in how women are treated during childbirth. Understanding drivers and structural dimensions of mistreatment, including gender and social inequalities, is essential to ensure that interventions adequately account for the broader context. United States Agency for International Development and the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, WHO.

Sections du résumé

BACKGROUND
Women across the world are mistreated during childbirth. We aimed to develop and implement evidence-informed, validated tools to measure mistreatment during childbirth, and report results from a cross-sectional study in four low-income and middle-income countries.
METHODS
We prospectively recruited women aged at least 15 years in twelve health facilities (three per country) in Ghana, Guinea, Myanmar, and Nigeria between Sept 19, 2016, and Jan 18, 2018. Continuous observations of labour and childbirth were done from admission up to 2 h post partum. Surveys were administered by interviewers in the community to women up to 8 weeks post partum. Labour observations were not done in Myanmar. Data were collected on sociodemographics, obstetric history, and experiences of mistreatment.
FINDINGS
2016 labour observations and 2672 surveys were done. 838 (41·6%) of 2016 observed women and 945 (35·4%) of 2672 surveyed women experienced physical or verbal abuse, or stigma or discrimination. Physical and verbal abuse peaked 30 min before birth until 15 min after birth (observation). Many women did not consent for episiotomy (observation: 190 [75·1%] of 253; survey: 295 [56·1%] of 526) or caesarean section (observation: 35 [13·4%] of 261; survey: 52 [10·8%] of 483), despite receiving these procedures. 133 (5·0%) of 2672 women or their babies were detained in the facility because they were unable to pay the bill (survey). Younger age (15-19 years) and lack of education were the primary determinants of mistreatment (survey). For example, younger women with no education (odds ratio [OR] 3·6, 95% CI 1·6-8·0) and younger women with some education (OR 1·6, 1·1-2·3) were more likely to experience verbal abuse, compared with older women (≥30 years), adjusting for marital status and parity.
INTERPRETATION
More than a third of women experienced mistreatment and were particularly vulnerable around the time of birth. Women who were younger and less educated were most at risk, suggesting inequalities in how women are treated during childbirth. Understanding drivers and structural dimensions of mistreatment, including gender and social inequalities, is essential to ensure that interventions adequately account for the broader context.
FUNDING
United States Agency for International Development and the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, WHO.

Identifiants

pubmed: 31604660
pii: S0140-6736(19)31992-0
doi: 10.1016/S0140-6736(19)31992-0
pmc: PMC6853169
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1750-1763

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.

Références

Reprod Health. 2014 Sep 19;11(1):71
pubmed: 25238684
Lancet Glob Health. 2019 May;7(5):e624-e632
pubmed: 30898495
Health Policy Plan. 2018 Jan 1;33(1):e26-e33
pubmed: 29304252
Midwifery. 2016 Sep;40:114-23
pubmed: 27428107
Health Policy Plan. 2018 Apr 1;33(3):317-327
pubmed: 29309598
Int J Environ Res Public Health. 2019 Feb 07;16(3):
pubmed: 30736396
BJOG. 2015 Jul;122(8):1045-9
pubmed: 25929823
Reprod Health. 2017 Sep 6;14(1):111
pubmed: 28877701
BMC Pregnancy Childbirth. 2015 Nov 23;15:306
pubmed: 26596353
Reprod Health. 2017 Jan 17;14(1):9
pubmed: 28095911
Cochrane Database Syst Rev. 2019 Mar 18;3:CD012449
pubmed: 30883666
Reprod Health. 2015 Apr 16;12:33
pubmed: 25890317
Bull World Health Organ. 2014 Dec 1;92(12):915-7
pubmed: 25552776
Reprod Health. 2017 Oct 11;14(1):127
pubmed: 29020966
BMC Med Res Methodol. 2018 Nov 15;18(1):132
pubmed: 30442102
PLoS Med. 2015 Jun 30;12(6):e1001847; discussion e1001847
pubmed: 26126110
BJOG. 2018 Jul;125(8):932-942
pubmed: 29117644
BMC Pregnancy Childbirth. 2015 Sep 22;15:224
pubmed: 26394616
Reprod Health. 2018 Feb 6;15(1):23
pubmed: 29409519
Cochrane Database Syst Rev. 2013 Oct 09;(10):CD003934
pubmed: 24105444
Reprod Health Matters. 2018;26(53):88-106
pubmed: 30132403
J Acquir Immune Defic Syndr. 2014 Dec 1;67 Suppl 4:S228-34
pubmed: 25436822
Lancet Glob Health. 2019 Jan;7(1):e96-e109
pubmed: 30554766
Epidemiol Health. 2018 Jul 1;40:e2018029
pubmed: 30056644
Reprod Health Matters. 2018;26(53):1-5
pubmed: 30293528
Reprod Health. 2018 Mar 27;15(1):54
pubmed: 29587802
PLoS One. 2018 Mar 16;13(3):e0194601
pubmed: 29547632
Cochrane Database Syst Rev. 2017 Jul 06;7:CD003766
pubmed: 28681500
BMC Pregnancy Childbirth. 2016 Aug 19;16:236
pubmed: 27543002
Reprod Health. 2015 Jul 22;12:60
pubmed: 26198988
Bull World Health Organ. 2018 Mar 1;96(3):222-224
pubmed: 29531422
PLoS One. 2018 Jul 11;13(7):e0200318
pubmed: 29995939
Lancet Glob Health. 2018 Nov;6(11):e1196-e1252
pubmed: 30196093
Reprod Health. 2015 May 26;12:50
pubmed: 26006320
Reprod Health. 2017 May 16;14(1):60
pubmed: 28511685
Reprod Health. 2017 Nov 15;14(1):149
pubmed: 29141640
SSM Popul Health. 2016 Dec;2:640-655
pubmed: 28345016
Reprod Health Matters. 2018;26(53):6-18
pubmed: 30189791
Reprod Health. 2017 Jan 11;14(1):3
pubmed: 28077145
Reprod Health. 2017 Jan 13;14(1):4
pubmed: 28086975
BMC Pregnancy Childbirth. 2019 Jan 22;19(1):39
pubmed: 30669981
Int J Gynaecol Obstet. 2015 Feb;128(2):110-3
pubmed: 25476154
Reprod Health Matters. 2018;26(53):70-87
pubmed: 30152268
Int J Gynaecol Obstet. 2018 Feb;140(2):184-190
pubmed: 29044510

Auteurs

Meghan A Bohren (MA)

Gender and Women's Health Unit, Centre for Health Equity, Melbourne School of Population and Global Health, University of Melbourne, Carlton, VIC, Australia; UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland. Electronic address: meghan.bohren@unimelb.edu.au.

Hedieh Mehrtash (H)

UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.

Bukola Fawole (B)

Department of Obstetrics and Gynaecology, National Institute of Maternal and Child Health, College of Medicine, University of Ibadan, Ibadan, Nigeria.

Thae Maung Maung (TM)

Department of Medical Research, Yangon, Myanmar.

Mamadou Dioulde Balde (MD)

Cellule de Recherche en Sante de la Reproduction en Guinee (CERREGUI), Conakry, Guinea.

Ernest Maya (E)

Department of Population, Family and Reproductive Health, School of Public Health, University of Ghana, Legon, Ghana.

Soe Soe Thwin (SS)

UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.

Adeniyi K Aderoba (AK)

Department of Obstetrics and Gynaecology, Mother and Child Hospital, Oke-Aro, Akure, Ondo State, Nigeria.

Joshua P Vogel (JP)

Maternal and Child Health Program, Burnet Institute, Melbourne, VIC, Australia.

Theresa Azonima Irinyenikan (TA)

Department of Obstetrics and Gynaecology, Faculty of Clinical Sciences, University of Medical Sciences, Ondo, Ondo State, Nigeria; University of Medical Sciences Teaching Hospital, Akure, Ondo State, Nigeria.

A Olusoji Adeyanju (AO)

Adeoyo Maternity Teaching Hospital, Yemetu, Ibadan, Oyo State, Nigeria.

Nwe Oo Mon (NO)

Department of Medical Research, Yangon, Myanmar.

Kwame Adu-Bonsaffoh (K)

Department of Obstetrics and Gynaecology, School of Medicine and Dentistry, Unive rsity of Ghana, Accra, Ghana.

Sihem Landoulsi (S)

UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.

Chris Guure (C)

Department of Biostatistics, School of Public Health, University of Ghana, Legon-Accra, Ghana.

Richard Adanu (R)

School of Public Health, University of Ghana, Legon-Accra, Ghana.

Boubacar Alpha Diallo (BA)

Cellule de Recherche en Sante de la Reproduction en Guinee (CERREGUI), Conakry, Guinea.

A Metin Gülmezoglu (AM)

UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.

Anne-Marie Soumah (AM)

Cellule de Recherche en Sante de la Reproduction en Guinee (CERREGUI), Conakry, Guinea.

Alpha Oumar Sall (AO)

Cellule de Recherche en Sante de la Reproduction en Guinee (CERREGUI), Conakry, Guinea.

Özge Tunçalp (Ö)

UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH